Qianjiang Yongan Pharmaceutical (002365.SZ) issued an announcement that the company ("Party A") and Hubei Yongbang Engineering Technology Co., Ltd...
According to a report from Zhitong Finance APP, Qianjiang Yongan Pharmaceutical (002365.SZ) announced that the "2024 Equipment Processing and Manufacturing Framework Agreement" signed with Hubei Yongbang Engineering Technology Co., Ltd. (hereinafter referred to as "Hubei Yongbang" or "Party B") is about to expire. Due to the company's production process improvement and equipment updating and transformation needs, the company intends to entrust Hubei Yongbang to continue providing processing and manufacturing Business that meets the technical quality Indicators and other requirements of the company and its subsidiaries, specifically including equipment manufacturing and installation, electromechanical equipment and pipeline installation, and other related engineering business, with a total transaction amount not exceeding RMB 20 million.
The company convened the fourth temporary meeting of the seventh Board of Directors on December 25, 2024, to review and approve the proposal on signing the <2025 Equipment Processing and Manufacturing Framework Agreement> with Hubei Yongbang Engineering Technology Co., Ltd. and related transactions, agreeing that the company and its subsidiaries will sign the "2025 Equipment Processing and Manufacturing Framework Agreement" with Hubei Yongbang. The agreement will take effect from the date of approval by this Board of Directors and will be valid for one year.
